Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis.

Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q36891502

about

High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.The endocannabinoid system links gut microbiota to adipogenesis Genetically modified flax expressing NAP-SsGT1 transgene: examination of anti-inflammatory action.Endocannabinoids in liver disease.Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis An amphipathic alpha-helical peptide from apolipoprotein A1 stabilizes protein polymer vesicles.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.A multi-mineral natural product inhibits liver tumor formation in C57BL/6 mice.Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.Intestinal GATA4 deficiency protects from diet-induced hepatic steatosis Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis HDL as a biomarker, potential therapeutic target, and therapy Structure and function of HDL mimetics.Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.Liver sinusoidal endothelial cells in hepatic fibrosis The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression.Proteomic Analysis Reveals Dab2 Mediated Receptor Endocytosis Promotes Liver Sinusoidal Endothelial Cell Dedifferentiation.Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin.The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis.Liver Sinusoidal Endothelial Cell: An Update.A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies.Role of canonical Hedgehog signaling pathway in liver

P2860

Q26996600-40D9CF67-3DB3-4A9A-A77A-40ACBF30D194 Q33556288-9ECE387D-E1AC-457D-9310-878149F51E43 Q33714587-388AE38B-447F-4CAB-B9B5-77609613D7AA Q34078880-64392841-AC11-4E62-AF72-7E6552219CB4 Q34358991-7A8010A8-A8CD-4BD3-A441-C49FA55178C6 Q34776919-CDC79CA4-E128-45A4-B7C6-143C32423612 Q35056710-EF2714DF-75FF-43DC-8613-09C1087D05E8 Q35082742-1A9D2144-C59B-4112-B53B-1DAEFC8F0501 Q35193292-E5EF43FA-C34F-432E-A6FB-07254C0DBAE4 Q35474335-EEF11271-386A-48AF-BAEF-EE7804059C95 Q35562084-2193BDD7-2950-4EC7-9C72-3FD4CAF8271E Q35990259-EA6CC25B-EA8F-4262-AE31-660BEAD069E4 Q36295444-7FEE90F1-9655-440F-A5F3-484C7B3F9FA2 Q36336508-87D4C7D1-D31F-4304-A7E3-443292ABECF1 Q36591996-981EA2F3-1EB1-45A0-AC37-572C1013570A Q36677171-CAF7187F-C66B-4319-9879-13619918E3CC Q36746393-81AEE88C-2053-4306-BA54-141E71020497 Q36763561-A6092358-E389-45B5-B5B8-97D3BDF68248 Q37164508-602A743C-91FC-44FB-AFDA-35DBFF1DC25B Q37429173-52CFA5CC-4A0D-402E-AB4C-FD435D727DE0 Q37553765-5B7CB98F-7970-4CC3-88C6-74EA51644BB3 Q37581457-C8DF4FE4-8D86-4D03-A606-5E792C7E03E3 Q38240680-56812356-8B08-4F2A-89EE-2AF86A54087E Q38527356-32C24738-8F30-4ED5-84C6-1294ED107F1C Q39031169-576360EE-4D7B-4135-B195-1A6E875007BC Q42677444-85649E5E-1F25-48EC-96F2-1DBA6A878F1C Q46503559-47EF99E7-F175-4366-BB76-B7E9057062BA Q47126762-CBD67373-ECF9-48A0-995C-8F7C939638A7 Q49612880-15371C0C-6E88-473D-8F4A-488EF44CF6FD Q50526595-BF53C012-74CE-433B-9C6D-F5C027EC7F40 Q58758006-D4690554-60DB-496A-8B8A-FB8388F92B80

P2860

Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q36891502

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Prevention of hepatic fibrosis ...... nonalcoholic steatohepatitis.

@en

type

label

Prevention of hepatic fibrosis ...... nonalcoholic steatohepatitis.

@en

prefLabel

Prevention of hepatic fibrosis ...... nonalcoholic steatohepatitis.

@en

P1433

Q36891502-2EAFFDA9-9144-4C1C-B365-EEAB11C6877E

P1476

Q36891502-EA7DBB10-4E49-4168-88D7-0BB1CFAEA3A8

P2093

Q36891502-3EA5EE69-49C5-43E1-84E0-AC5698F86736

Q36891502-B7647C51-6B79-4950-8EE0-BA8C77B38132

Q36891502-B99D87CB-96DB-4259-ADE3-F63CC74A3AC6

Q36891502-DB0B7E2A-3BBE-49A3-AF7B-0C016C606978

Q36891502-F87884C4-0BD1-4FFE-9B53-E21F2C93F4CA

P2860

Q36891502-0693B77B-554C-411B-9114-F286275A1ECE

Q36891502-19F140CC-B711-4916-9EA5-D345D9E1BE8E

Q36891502-1D92178B-54A9-4415-9505-5950E45B49E8

Q36891502-1EB92D02-7FFE-4FFE-9F17-ABE3494CE096

Q36891502-217CA025-6D65-4CBC-81C2-C43F0494DBB6

Q36891502-2587F34D-DF28-4B9F-AB41-E09E211F4E7A

Q36891502-2E2EB219-EFA0-4B4A-846F-A6E4330512BB

Q36891502-32510FF0-145E-495B-98CE-4E2CDF56BA9C

Q36891502-3D27DFA2-122D-4286-A564-440F7C47AB20

Q36891502-421752B0-B579-4451-82EB-552E6A67792F

P304

Q36891502-232C7BC2-0D0B-41DA-9DAB-8A66E62D9CD6

P31

Q36891502-FED8DBE7-E190-4C8D-95D5-812C45AA871A

P356

Q36891502-206EE0C1-E527-4FD2-9D8B-D247BC8892E9

P407

Q36891502-2DF7DA9A-9D25-433F-94BC-DEFDA4F64B39

P433

Q36891502-A5905B0E-1DBF-44AB-8083-E776D7796979

P478

Q36891502-4BEBB8FE-8298-4C5D-8472-22D163E6EDDB

P577

Q36891502-3FB20994-95A9-471A-8C68-4770392A8915

P5875

Q36891502-33A35327-66EC-4E79-9524-947BC1437684

P698

Q36891502-0CCA8B24-1C69-47AE-8FC3-E7E15A24D933

P921

Q36891502-0958ED7D-F68A-497D-B213-83235EE08041

Q36891502-D0562B96-62F1-4385-83AA-0E5E0848C58E

P932

Q36891502-381DBF4B-E054-4C97-9DA9-51D8053E5710

P356

AJPATH.2008.070720

P1433

The American Journal of Pathology

P1476

Prevention of hepatic fibrosis ...... nonalcoholic steatohepatitis.

@en

P2093

Gary C Kanel

http://www.w3.org/2001/XMLSchema#string

Laurie D DeLeve

http://www.w3.org/2001/XMLSchema#string

Robert S McCuskey

http://www.w3.org/2001/XMLSchema#string

Roscoe D Atkinson

http://www.w3.org/2001/XMLSchema#string

Xiangdong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells.

Pathogenesis of liver fibrosis: role of oxidative stress.

Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.

Hepatic microcirculation in fatty liver disease.

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver.

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice.

P304

993-1001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2008.070720

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23238428

http://www.w3.org/2001/XMLSchema#string

P698

18772330

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

metabolic syndrome

P932

2543068

http://www.w3.org/2001/XMLSchema#string